Building breath, layer by layer: 3D printing with living lung cells in extreme environments

Researchers at Texas A&M University model extreme conditions using 3D bioprinting, revealing insights that could make flight ...
CURE

How New Therapies Are Changing the Game for Small Cell Lung Cancer

Dr. Charles M. Rudin highlighted new small cell lung cancer therapies, including T cell engagers, antibody-drug conjugates, ...
AlphaGalileo

Anti-angiogenic therapy as a beacon of hope in the battle against pulmonary NUT midline carcinoma

Primary pulmonary nuclear protein of the testis (NUT) midline carcinoma (NMC) is an extremely rare, highly aggressive thoracic malignancy that ...

The Hard Reality of Frontotemporal Dementia: Beyond the Research Hype

We break down the current state of frontotemporal dementia, from bvFTD to PPA, and why 'promising' therapies are still far ...

US FDA approves Novartis' gene therapy for rare muscle disorder

The U.S. Food and Drug Administration has approved Novartis' gene therapy for patients with a rare muscle disorder, the drugmaker said on Monday.

Key immune differences in triple-negative breast cancer uncovered

Researchers at the LSU LCMC Health Cancer Center have published findings in npj Breast Cancer that shed new light on ...
Healio

Cystic fibrosis triple therapy linked to reductions in airway, systemic inflammation

Among adults and adolescents with cystic fibrosis starting triple therapy for the first time, inflammatory markers fell and ...
The American Journal of Managed Care

TMP-SMX Linked to Higher 30-Day Respiratory Failure Risk in Adolescents and Young Adults

Adolescents and young adults on TMP-SMX have a higher 30-day risk of acute respiratory failure than those on amoxicillin or cephalosporins. The study supports the FDA's warning about TMP-SMX, with ...